The PFS rates at 6, 12, and 18 months in the HPL group were 82.1%, 43.4%, and 31.2%, respectively, The PFS rate of the HDL group showed a trend of being superior to the HPL group, but there was still no statistically significant difference.
← all excerpts
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma.
1
—
—